Search

Global research spending soared in 2007, with Microsoft pulling into the lead. But don’t expect a repeat this year, warns Commissioner Potočnik.

The credit crunch is strangling biotech. And with no access to capital, the only way out is to sell to big pharma.

Who can deliver on science and innovation? I can, says the UK’s new Science Minister, Paul Drayson.

As stock markets turn their backs on the high-risk sectors, France Biotech’s annual survey reveals the depths to which investment has fallen.

The European Commissioner for Science and Research gave a first progress report on the European Research Council at a meeting in Paris this week.

Sweden’s industrial development fund failed to sell any shares in portfolio companies in 2007–2008 and wrote down the value of its life sciences investments.

The UK is to invest in a nationwide network of cancer imaging research centres that will apply the latest imaging technologies to basic and clinical research.